AstraZeneca Genetic "Vaccine" Removed from the Market
More Fact Checking of the Fact Checkers....Genetic "Vaccines" Do Cause Blood Clots
Coagulopathies are conditions under which any excessive bleeding or clotting is observed. The disease states in which coagulopathies are implicated include heart attack, stroke, embolisms, aneurysm, deep-vein thrombosis, and red blood cell and platelet abnormalities such as thrombocytopenia as well as, genetic conditions which predispose to these pathologies.
AstraZeneca genetic vaccine removed from the market in May 2024
Source: https://www.fiercebiotech.com/research/covid-shot-blood-clots-share-genes-condition-linked-common-cold#:~:text=It%20was%20removed%20from%20the,to%20a%20decline%20in%20demand.
The headline states the adenovirus based genetic “vaccine” cause blood clots but the story claims it was removed from the market due to decline in demand.
AstraZeneca’s vaccine, Vaxzevria, was dogged by reports of VITT not long after the shot rolled out in Europe. Soon after, news of VITT in six U.S. patients who took the J&J vaccine emerged as well, prompting officials to pause it to investigate and later restrict its use. It was removed from the market entirely two years later. AstraZeneca’s shot remained available in some parts of Europe until May 2024, when the company requested its marketing approval be revoked due to a decline in demand.
In a letter published May 15 in The New England Journal of Medicine, an international team of scientists explained that people who carry certain variants of a gene called IGLV3-21*02 are predisposed to developing both vaccine-induced immune thrombocytopenia and thrombosis (VITT) and the same type of reaction after infection with the adenovirus. Both the J&J and AstraZeneca vaccines are delivered to the body in adenovirus vectors, which explains why the etiology of the conditions is the same.
J&J’s genetic vaccine was pulled from the market in May 2023 due to issues with coagulopathy.
Some of us called this out very early in the rollout of the genetic “vaccines” but were ignored and/or fact checked.
How would you feel if you took one of these genetic vaccines and they have now been removed from the market? Leave me a comment below.
Let’s continue examining the fact check of the claims made by Dr. Janci Lindsay in April 2021.
Claim 2: Reported blood clots were caused by the COVID-19 genetic vaccines.
Lindsay claimed that “all of the gene therapies [COVID-19 vaccines] are causing coagulopathy.”
AFP FACT CHECK
AFP responded stating, “Scientists have widely rejected the unsubstantiated claim that mRNA vaccines can modify human DNA.” But they did admit there have been reports of blood clots associated with low platelets following vaccination with the adenoviral (non-mRNA) vaccines from Johnson & Johnson/Janssen and Oxford/AstraZeneca, but these events are very rare.
HEALTH FEEDBACK FACT CHECK
“Lindsay based this claim on a September 2020 study showing that the spike protein produced during SARS-CoV-2 infection can bind platelets and promote the formation of blood clots in an experimental mouse model.
Lindsay assumed, without providing any evidence, that the spike protein produced after COVID-19 vaccination would have the same effect. However, the results from the studies evaluating the effect of the spike protein produced during infection are still preliminary. Furthermore, the spike protein from infection behaves differently from that produced by COVID-19 vaccines.”
What studies is the author basing this statement on? How does the author know that the spike protein from infection behaves differently from that produced by the COVID-19 genetic vaccines?
WHAT THE DATA SHOWS
Keep reading with a 7-day free trial
Subscribe to Smith's Virology Blog to keep reading this post and get 7 days of free access to the full post archives.